Therapeutic mAb Binding CQA Characterization Using AR-SEC-MS
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for assessing critical quality attributes (CQAs) of therapeutic monoclonal antibodies (mAbs) related to target binding and Fc receptor engagement are laborious, challenging, and often require variant enrichment, which can be difficult for low-abundance variants, and may not provide accurate results due to the need for artificial stress conditions.
Innovation Solution
An affinity-resolved size exclusion chromatography-mass spectrometry (AR-SEC-MS) method that separates bound and unbound mAb species based on hydrodynamic radii, followed by post-column denaturation to analyze their masses, allowing direct characterization of binding interactions without the need for variant enrichment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If variant enrichment methods are used to assess CQAs, then measurement precision may be improved, but device complexity and ease of operation deteriorate due to laborious procedures and difficult enrichment of low-abundance variants
Solution Approach 1:
The patent extracts the binding assessment function from complex enrichment procedures by directly analyzing bound and unbound mAb species through size exclusion chromatography coupled with mass spectrometry. This eliminates the need for variant enrichment steps while maintaining accurate CQA assessment, thereby simplifying the operational process.
Solution Approach 2:
The AR-SEC-MS method serves multiple functions simultaneously: it separates bound and unbound species, identifies mAb variants through mass spectrometry, and assesses binding affinities all in a single workflow. This multi-functionality replaces multiple separate enrichment and analysis steps, improving ease of operation while maintaining measurement precision.
2Measurement precision
If variant enrichment is performed, then measurement precision may improve, but loss of time increases due to laborious enrichment procedures
Solution Approach 1:
The patent implements continuous analysis by coupling size exclusion chromatography directly with mass spectrometry detection. The system continuously separates and detects bound and unbound mAb species without interruption, eliminating the time-consuming batch enrichment steps while maintaining accurate measurement of CQAs.
Solution Approach 2:
The method performs preliminary separation of bound and unbound species through size exclusion chromatography before detection, allowing direct analysis without subsequent enrichment steps. This preliminary action eliminates time loss associated with multiple enrichment cycles while ensuring accurate CQA assessment.
3Measurement precision
If artificial stress conditions are applied, then measurement precision may improve for detecting low-abundance variants, but reliability deteriorates due to potential artifacts
Solution Approach 1:
The patent employs the inherent size difference between bound and unbound mAb species as a natural separation mechanism through size exclusion chromatography. This self-service approach eliminates the need for artificial stress conditions, allowing direct detection of low-abundance variants in their native state, thereby maintaining both precision and reliability.
Solution Approach 2:
The method changes the detection parameter from requiring enriched samples to directly detecting bound complexes based on their hydrodynamic radius. By monitoring mass-to-charge ratio of separated species, the system achieves sensitive detection of low-abundance variants without artificial stress, preserving result accuracy.
4Measurement precision
If complex enrichment procedures are used, then measurement precision may improve, but device complexity increases
Solution Approach 1:
The patent merges size exclusion chromatography with mass spectrometry detection into a coupled AR-SEC-MS system. This integration allows simultaneous separation and identification of bound and unbound species in a single workflow, eliminating the need for separate enrichment devices and procedures, thereby reducing overall device complexity while maintaining measurement precision.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Provides rapid, multiplexed assessment of CQAs by enriching mAb variants with higher or lower binding affinities into bound or unbound forms, enabling simultaneous comparison of binding affinities and understanding the impact of post-translational modifications on mAb function.
Implementation Method 1
separating the mixture on a liquid chromatography column to separate the protein-antigen complex from the protein that is not bound to the antigen
Implementation Method 2
determining a mass of the protein-antigen complex and a mass of the protein that is not bound to the antigen with a mass spectrometer
Data Source
AI summary
The present disclosure generally pertains to methods for identifying the binding of a peptide or protein to a binding partner using affinity-resolved size exclusion chromatography coupled to mass spectrometry.